the Stock Exchange of Thailand The Company would like to clarify the net profit for the 9-month periods of the year ending on 30th September 2018 had decreased more than 20% comparing to the same period
previous Quarterly To: The President The Stock Exchange of Thailand As a result of the global economic slowdown, trade and economic negotiations and in Thailand have continued to slow down to wait for
แบบแสดงรายการข้อมูลสำหรับการเสนอขายหลักทรัพย์ (แบบ 69-1) 1 No. WHAUP-CS016/2017 August 11, 2017 Attention: Managing Director – Stock Exchange of Thailand Subject: Report of Financial Results for the
Page 1 of 3 GEL.CS.003/2562 28 February 2019 Subject: Management Discussion and Financial Analysis for the operating results as at December 31, 2018 To: Director and Manager The Stock Exchange of
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
: EIC-AD052/2017 November 13, 2017 Subject: Management Discussion and Analysis of the Operating Performance for Quarter 3 Ending September 30, 2017 To: President and Director The Stock Exchange of
Microsoft Word - ACE MDA YE21 - EN_Final 1 No. ACE-ACC-1/2022 28 February 2022 Subject Management Discussion and Analysis for the year ended 31 December 2021 To President The Stock Exchange of
analysis report of the financial positions and result of business operations differences more than 20% compare to the previous year. To : Board of Governors and the President of The Stock Exchange of
President The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 2nd quarter of 2019. The MD&A would enable the
Company’s land (additional disclosure) To: The President The Stock Exchange of Thailand The Board of directors meeting # 8/2019 held on June 4, 2019 has a resolution to sell a piece of land to increase